Wednesday, July 8, 2026

pharma · Stargardt Disease · Muscle Relaxation · ELTP

ELITE PHARMACEUTICALS INC

ELITE PHARMACEUTICALS INC is a pharma organization headquartered in Northvale, USA. It trades on NYSE under ticker ELTP. Primary therapeutic focus areas include Stargardt Disease, Muscle Relaxation, Geographic Atrophy, D

Northvale, USA HQ
1996 Founded
64 Employees
Public company Type
ELTP · NYSE Ticker
Company details
Clinical program

GSK2330672

Phase 2 · small molecule · Diabetes Mellitus, Type 2

GSK2330672 for Diabetes Mellitus, Type 2 is a Phase 2 program (small_molecule) at ELITE PHARMACEUTICALS INC /NV/ with 1 ClinicalTrials.gov record(s).

← All ELITE PHARMACEUTICALS INC /NV/ projects Phase 2 small molecule completed

Internal code 200185

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
ELITE PHARMACEUTICALS INC /NV/
Phase
Phase 2
Modality
small_molecule
Indication
Diabetes Mellitus, Type 2
Status
completed
Trials
1

Clinical trials